STAT | The PASTEUR Act is being reintroduced to the House and the Senate. The legislation urges the US government to restructure the federal payment protocol into a subscription program that will pay for antimicrobials according to their value, not the quantity of pills sold. Furthermore, it will boost data collection at hospitals which could receive federal funding to participate in an anti-overuse program. Boston University Professor and CARB-X Executive Director Kevin Outterson said that the proposed legislation is a game-changer for the AMR innovation gap and the final missing piece in the US National Action Plan on Combating Antibiotic-Resistant Bacteria.